North Star Investment Management »

Oncternal Therapeutics shares owned by North Star Investment Management

Quarter-by-quarter ownership of Oncternal Therapeutics (ONCT) shares owned by North Star Investment Management from 13F filings

Historical chart of North Star Investment Management investment in Oncternal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oncternal Therapeutics held by North Star Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncternal Therapeutics by North Star Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.3k 250 9.00
2023-12-31 $2.7k 5.0k 0.54

More positions owned by North Star Investment Management

JPMorgan Chase & Co. (JPM)
Apple (AAPL)
Ishares Tr S&p 500 Grwt Etf (IVW)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr S&p 500 Val Etf (IVE)
Old Republic International Corporation (ORI)
Blackstone Group Inc Com Cl A (BX)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Abbvie (ABBV)
Kkr & Co (KKR)
Acme United Corporation (ACU)

View all positions for North Star Investment Management

Top funds holding Oncternal Therapeutics

Aureus Asset Management
North Star Investment Management
Bnp Paribas Arbitrage, Snc
Lindbrook Capital

View all funds holding Oncternal Therapeutics